We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) ended the recent trading session at $29.50, demonstrating a -4.13% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.14% for the day. Elsewhere, the Dow saw a downswing of 0.01%, while the tech-heavy Nasdaq depreciated by 0.57%.
Shares of the company have appreciated by 2.81% over the course of the past month, outperforming the Finance sector's gain of 2.55%, and the S&P 500's gain of 0.25%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on August 6, 2026. It is anticipated that the company will report an EPS of $0.45, marking a 150.56% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $4.89 billion, indicating a 70.85% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.59 per share and revenue of $18.77 billion, which would represent changes of +134.91% and +60.4%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 24.82% higher. Oscar Health, Inc. is holding a Zacks Rank of #1 (Strong Buy) right now.
Valuation is also important, so investors should note that Oscar Health, Inc. has a Forward P/E ratio of 52.45 right now. This signifies a premium in comparison to the average Forward P/E of 10.02 for its industry.
Also, we should mention that OSCR has a PEG ratio of 1.72. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. OSCR's industry had an average PEG ratio of 1.06 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 169, placing it within the bottom 32% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Note
Oscar Health, Inc. (OSCR - Free Report) ended the recent trading session at $29.50, demonstrating a -4.13% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.14% for the day. Elsewhere, the Dow saw a downswing of 0.01%, while the tech-heavy Nasdaq depreciated by 0.57%.
Shares of the company have appreciated by 2.81% over the course of the past month, outperforming the Finance sector's gain of 2.55%, and the S&P 500's gain of 0.25%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on August 6, 2026. It is anticipated that the company will report an EPS of $0.45, marking a 150.56% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $4.89 billion, indicating a 70.85% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.59 per share and revenue of $18.77 billion, which would represent changes of +134.91% and +60.4%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 24.82% higher. Oscar Health, Inc. is holding a Zacks Rank of #1 (Strong Buy) right now.
Valuation is also important, so investors should note that Oscar Health, Inc. has a Forward P/E ratio of 52.45 right now. This signifies a premium in comparison to the average Forward P/E of 10.02 for its industry.
Also, we should mention that OSCR has a PEG ratio of 1.72. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. OSCR's industry had an average PEG ratio of 1.06 as of yesterday's close.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 169, placing it within the bottom 32% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.